Hyperbolic Tapering Antidepressants: The Complete Guide (2026)

Hyperbolic tapering is a method of safely discontinuing antidepressants by reducing the dose in progressively smaller steps — based on how antidepressants actually affect the brain, not on arbitrary fixed amounts. Unlike traditional tapering, it accounts for the non-linear relationship between dose and receptor occupancy, dramatically reducing the risk of withdrawal symptoms.

If you've tried to stop antidepressants and failed — or if your doctor handed you a "reduce by half every two weeks" schedule that left you in pieces — this guide is for you.

Table of Contents

• What is hyperbolic tapering?
• The neuroscience: why linear tapering fails
• Hyperbolic vs linear tapering — comparison
• How to do hyperbolic tapering step by step
• Tools: tapering strips, liquid formulations, compounding pharmacies
• Which antidepressants need hyperbolic tapering most?
• How long does hyperbolic tapering take?
• My personal experience with hyperbolic tapering
• Working with your doctor
• FAQ
   

What is hyperbolic tapering? 

Hyperbolic tapering is a neuroscience-based method for discontinuing antidepressants (SSRIs and SNRIs) in which dose reductions become progressively smaller as the dose decreases.

The term "hyperbolic" refers to the mathematical shape of the dose-response curve of antidepressants on serotonin receptors. Because this curve is hyperbolic — not linear — the dose reductions must also follow a hyperbolic pattern to keep the neurological impact of each reduction consistent.

The method was formally described by psychiatrists Mark Horowitz and David Taylor in a landmark 2019 paper published in The Lancet Psychiatry, though many patients had already discovered it intuitively through trial and error in online support groups.

In simple terms: instead of reducing by a fixed amount each time (e.g. 10mg → 5mg → 0), you reduce by a fixed percentage of the current dose (e.g. 10mg → 9mg → 8.1mg → 7.3mg...). The steps get smaller and smaller. This is what makes it hyperbolic.

The neuroscience: why linear tapering fails 

To understand why hyperbolic tapering works, you first need to understand why conventional tapering often doesn't.

The receptor occupancy curve
 

SSRIs work by blocking the reuptake of serotonin in the brain — but their effect on serotonin transporter (SERT) occupancy doesn't scale linearly with dose. The relationship is hyperbolic:

• At 20mg of sertraline: approximately 80% of SERT receptors are occupied
• At 10mg: approximately 70% occupied
• At 5mg: approximately 60% occupied
• At 2mg: approximately 45% occupied
• At 1mg: approximately 33% occupied
   

Notice something: the drop from 20mg to 10mg (cutting dose in half) only changes SERT occupancy by around 10 percentage points. But the drop from 5mg to 0 — eliminating what seems like a tiny dose — changes occupancy by 60 percentage points. That final jump to zero is neurologically enormous.

This is why people on conventional tapers feel fine through the first few reductions — and then collapse when they reach the end. Doctors often interpret this as relapse. It isn't. It's the predictable consequence of ignoring the receptor occupancy curve.

What the brain experiences

When you reduce dose too fast at low concentrations, the brain's serotonergic system — which has adapted to the presence of the drug — suddenly faces a massive functional change. The result is what we call antidepressant withdrawal syndrome: brain zaps, dizziness, emotional instability, insomnia, akathisia, depersonalization, and in some cases, protracted withdrawal that lasts months or years.

Hyperbolic tapering prevents this by keeping each dose reduction neurologically equivalent — ensuring the brain adapts gradually rather than being destabilized.

Hyperbolic vs linear tapering — comparison {#comparison}

The 2019 Lancet Psychiatry paper by Horowitz and Taylor was a turning point. It demonstrated mathematically why equal dose reductions produce unequal neurological effects — and proposed a clinical framework for hyperbolic tapering based on SERT occupancy data for the most common SSRIs and SNRIs.

A 2023 prospective study in the Netherlands followed 608 patients using hyperbolic tapering strips and found that withdrawal was limited and inversely proportional to the rate of tapering — meaning: the slower you go, the less you suffer.

How to do hyperbolic tapering step by step {#how-to}

This is a general framework. Your specific plan should be developed in collaboration with your prescribing physician.

Step 1: Stabilise first

Before reducing anything, ensure you are in a stable period — no major life stressors, no other medication changes, adequate sleep and nutrition. Trying to taper through a crisis amplifies withdrawal symptoms and increases failure rates.

Step 2: Establish your baseline dose

Note your current dose and how long you've been on it. The longer the duration and higher the dose, the more gradual your taper needs to be.

Step 3: Plan reductions of 10% of current dose

The standard starting point for hyperbolic tapering is reducing by approximately 10% of the current dose — not the original dose — every 4 weeks. This is very different from linear tapering.

Example for someone on 20mg sertraline:

Step 4: Observe and adjust

After each reduction, wait a minimum of 2-4 weeks before the next one. Some people need 6-8 weeks at lower doses. Watch for:

• Emergence of new symptoms (not present before starting medication) → slow down or hold
• Return of original symptoms (anxiety, depression identical to pre-medication state) → discuss with doctor, may signal actual relapse
• No significant symptoms → proceed to next reduction

Step 5: The final crossing to zero

This is the most critical step. The last dose should be very small — ideally below 1mg. Jumping from 5mg to zero is the most common cause of severe protracted withdrawal. Take your time here. The final 10% of the taper takes the most patience.

Tools: how to achieve hyperbolic doses {#tools}

Standard tablet sizes (e.g. 20mg, 10mg, 5mg) are insufficient for hyperbolic tapering. You need doses that don't exist commercially. Here's how to achieve them:

Tapering strips

Developed in the Netherlands by Prof. Peter Groot, tapering strips are packs of 28 sachets containing small beads with precisely measured, daily-decreasing doses. They are available for sertraline, paroxetine, venlafaxine, and a growing number of other antidepressants.

Tapering strips are the most precise tool available. They are currently available on prescription from specialist pharmacies in the Netherlands and are beginning to appear in other countries.

Liquid formulations

Many antidepressants are available in liquid form (oral solution), which allows precise dose measurement with a syringe. This is the most accessible option in most countries.

• Fluoxetine: 20mg/5ml solution widely available
• Sertraline: concentrate available in many countries
• Escitalopram: oral drops available in Europe
• Citalopram: oral drops available

Compounding pharmacies

Compounding pharmacies can prepare custom doses in capsule or liquid form. In Poland and the UK, this is increasingly accessible — ask your doctor for a compounding pharmacy referral.

Tablet splitting and weighing

For tablets without coatings, precise splitting and weighing with a 0.001g precision scale is possible at higher doses. This method is imprecise at very low doses and not recommended below 5mg.

Which antidepressants need hyperbolic tapering most? {#which}

All antidepressants benefit from hyperbolic tapering, but some are significantly more challenging than others due to short half-lives and high receptor affinity.

Highest risk (slow tapering essential):

• Paroxetine (Paxil / Seroxat) — shortest half-life, highest SERT occupancy at low doses
• Venlafaxine (Effexor) — dual mechanism (SNRI), short half-life, highly problematic at low doses
• Desvenlafaxine (Pristiq)

High risk:

• Sertraline (Zoloft)
• Escitalopram (Lexapro / Cipralex)
• Citalopram (Celexa)
• Duloxetine (Cymbalta)
• Fluvoxamine

Lower risk (but still benefits from hyperbolic approach):

• Fluoxetine (Prozac) — very long half-life acts as a natural buffer, but not self-tapering as sometimes claimed
• Mirtazapine

How long does hyperbolic tapering take? {#how-long}

This is the question everyone asks, and the honest answer is: it depends.

These are averages. Some people taper faster with minimal symptoms. Others — particularly those with previous failed attempts or a history of trauma — need to go slower. The tapering process is not linear; it involves "windows and waves" — periods of feeling fine followed by periods of symptoms. This is normal and does not mean the taper is failing.

My personal experience with hyperbolic tapering {#my-experience}

I spent 10 years on antidepressants. When I first tried to stop — using the schedule my psychiatrist gave me — I collapsed within weeks. The symptoms were nothing like my original depression. Brain zaps. Anhedonia so severe I couldn't feel love for the people closest to me. Sexual dysfunction that terrified me. Cognitive fog so thick I couldn't read a paragraph.

My doctors said it was relapse. I went back on the medication. Then tried again. And collapsed again.

It took me discovering the research of Mark Horowitz and David Taylor — and the communities at Surviving Antidepressants and Mad in America — to understand what was actually happening. This wasn't relapse. It was my brain, desensitised over a decade, screaming at being destabilised too fast.

I rebuilt my tapering plan from scratch. Hyperbolic. Personalised. Patient. Six years later, I am fully recovered — from both the withdrawal and from PSSD (Post-SSRI Sexual Dysfunction), which I developed during the failed fast tapers.

I now work 1:1 with people navigating what I went through, because I know this territory from the inside. Not just from research papers, but from living it.

If you want to read more about my story, visit the About me page.

Working with your doctor {#doctor}

Hyperbolic tapering requires prescriptions for doses that don't exist in standard commercial forms. This means you need a doctor willing to work with you.

Unfortunately, many psychiatrists and GPs are unfamiliar with hyperbolic tapering — and some actively resist it, citing the myth that antidepressants are "not addictive" and that withdrawal is brief and mild.

Here's how to approach the conversation:

What to say

"I've been reading about hyperbolic tapering, based on the Horowitz & Taylor 2019 paper in The Lancet Psychiatry. I'd like to try a slow, personalised taper rather than a standard reduction schedule. Can we discuss what this would look like and whether a compounding pharmacy could help?"

What to bring

• Horowitz, M., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538-546.
• The NICE guideline update (2022) recommending individualized, gradual tapering

If your doctor refuses

Seek a second opinion. Some patients work with specialist tapering support services (like the one I offer) to build a detailed tapering plan to present to their doctor for prescription support.

FAQ {#faq}

What does "hyperbolic" mean in hyperbolic tapering?

It refers to the mathematical shape of the dose-response curve of antidepressants on serotonin receptors. The curve is hyperbolic — meaning small doses have a disproportionately large effect. Because the drug's effect curve is hyperbolic, the dose reductions must also be hyperbolic (progressively smaller) to keep each neurological step consistent.

Is hyperbolic tapering safe?

Yes. It is considered safer than conventional linear tapering because it minimises the neurological disruption at each reduction step. The 2023 Dutch study of 608 patients using hyperbolic tapering strips found limited withdrawal symptoms that were inversely proportional to the tapering rate — the slower the taper, the fewer symptoms.

Can I do hyperbolic tapering with standard tablets?

At higher doses, yes — you can split tablets and, at some doses, weigh fragments. But below approximately 5mg, standard tablets are insufficient. Liquid formulations or compounding pharmacies are necessary for the final and most critical phases of the taper.

How is hyperbolic tapering different from the 10% method?

The 10% method (popularised by patient communities like Surviving Antidepressants) is essentially an approximation of hyperbolic tapering. Reducing by 10% of the current dose each time produces dose steps that roughly follow a hyperbolic curve. Formal hyperbolic tapering, as described by Horowitz and Taylor, is more precise — using SERT occupancy data for specific medications — but the 10% method is a practical and effective approximation for most people.

Who developed hyperbolic tapering?

The method was formally described by Dr. Mark Horowitz (UCL) and Professor David Taylor (King's College London) in a 2019 paper in The Lancet Psychiatry. Dr. Horowitz himself tapered off antidepressants using this method after experiencing severe withdrawal, making him uniquely qualified to both research and advocate for it.

What if my symptoms get worse during hyperbolic tapering?

Hold your current dose. Do not reduce further until symptoms stabilise — this may take 4-12 weeks. If symptoms are severe, discuss with your doctor whether a temporary partial reinstatement is appropriate. Do not jump back to your previous full dose without medical guidance, as this can cause its own set of complications.

Can hyperbolic tapering prevent protracted withdrawal?

It significantly reduces the risk. Protracted withdrawal — withdrawal symptoms lasting months or years after discontinuation — is strongly associated with fast tapers and abrupt discontinuation. Slow, hyperbolic tapering reduces the neurological disruption that appears to cause the dysregulation underlying protracted withdrawal. It does not guarantee prevention, but it is the single most effective protective measure available.

Is hyperbolic tapering only for antidepressants?

No. The same principles apply to benzodiazepines, antipsychotics, and other psychiatric medications that work on receptor systems. For benzodiazepines, the equivalent method involves diazepam equivalence switching and very slow reductions — the Ashton Manual remains a key reference, though it predates formal hyperbolic tapering research.

Resources and further reading

• Horowitz, M., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry.
• Groot, P., & Van Os, J. (2023). Outcomes of hyperbolic tapering of antidepressants. Therapeutic Advances in Psychopharmacology.
• Surviving Antidepressants — peer support community with extensive tapering resources
• Mad in America — critical psychiatry journalism and research
• RxISK — drug side effect reporting and research

Need personalised hyperbolic tapering support?

I offer 1:1 consultations for people who want a personalised hyperbolic tapering plan — built around your specific medication, dose, history, and nervous system.

Having spent 10 years on antidepressants and 6 years recovering from protracted withdrawal and PSSD, I understand this process from both sides: the research and the lived experience.

Book a free discovery call → Read about how I work → Learn about protracted withdrawal →

Author: Tomasz Starczewski — specialist in hyperbolic tapering and protracted withdrawal recovery. Cognitive scientist (Nicolaus Copernicus University, Toruń) and neurobiologist (Medical University of Silesia, Katowice). Recovered from PSSD and protracted antidepressant withdrawal after 10 years on psychiatric medication. Published in Mad in America and cited in RxISK.

This article is for educational purposes only and does not constitute medical advice. Always work with your prescribing physician before making any changes to your medication.

FIND OUT MORE

© 2026 Protracted Withdrawal

Adress

Tomasz Starczewski "Protracted Withdrawal"
TIN (VAT ID): 6472501072

ul. Hermanowska 99
54-314 Wrocław, Poland

Contact

contact@protracted-withdrawal.com
791 001 154

Menu

Follow me